KLA Corporation (KLAC) 8-K Current Report: March 12, 2026

Filed: March 12, 2026
Health Care
Optical Instruments & Lenses

KLA Corporation (KLAC) 8-K current report filed with SEC EDGAR on March 12, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

  • Item 7.01: Regulation FD Disclosure
  • Item 8.01: Other Events

KLA Corporation 8-K Mar 12, 2026 Event Analysis

Item 7.01 · Regulation FD Disclosure

  • KLA hosted Investor Day on March 12, 2026, featuring CEO Richard Wallace and CFO Bren Higgins alongside senior management
  • Full presentation slides and webcast replay available at ir.kla.com — primary source for any financial targets or strategic updates disclosed
  • Reg FD filing ensures public investor access to same information presented to institutional attendees

Item 8.01 · Other Events

  • Quarterly dividend raised to $2.30/share, a 21% increase from $1.90/share declared February 2026, effective May 2026
  • New $7B share repurchase program authorized, added on top of prior $5B program (April 2025)
  • Combined buyback capacity: ~$10.94B ($3.94B remaining from prior program + new $7B)
  • Shareholder return signal: simultaneous dividend hike and buyback expansion reflects strong Board confidence in cash generation outlook

Get deeper insights on KLA Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.